MBX Biosciences Inc. (MBX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.85
Day's range
$30.53

MBX Biosciences Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 6.65 M $367.19 M   0.00% 13.95%
FMR LLC 08/13/2026 5.32 M $293.82 M   81.25% 11.16%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 4.98 M $274.76 M   55.95% 10.44%
NEA MANAGEMENT COMPANY, LLC 08/14/2026 3.61 M $199.52 M   0.00% 7.58%
ORBIMED ADVISORS LLC 08/14/2026 3.43 M $189.27 M   -5.75% 7.19%
BLACKROCK, INC. 08/07/2026 3.32 M $183.47 M   13.00% 6.97%
PARADIGM BIOCAPITAL ADVISORS LP 08/14/2026 2.51 M $138.44 M   100.00% 5.26%
NVP ASSOCIATES, LLC 08/07/2026 2.14 M $117.93 M   0.00% 4.48%
DEEP TRACK CAPITAL, LP 08/14/2026 1.73 M $95.64 M   -37.17% 3.63%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.61 M $88.79 M   -0.84% 3.37%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.48 M $81.55 M   -0.01% 3.10%
AARON WEALTH ADVISORS LLC 07/16/2026 1.17 M $64.46 M   -0.03% 2.45%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 1.06 M $58.32 M   3.77% 2.22%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 934.80 K $51.60 M   0.00% 1.96%
WOODLINE PARTNERS LP 08/14/2026 900.09 K $49.69 M   0.00% 1.89%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 873.49 K $48.22 M   -1.85% 1.83%
STATE STREET CORP 08/07/2026 864.47 K $47.72 M   9.81% 1.81%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 814.81 K $44.98 M   -20.82% 1.71%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2026 800.17 K $44.17 M   0.02% 1.68%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 773.07 K $42.68 M   15.32% 1.62%
BRAIDWELL LP 08/14/2026 710.88 K $39.24 M   -52.37% 1.49%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 650.00 K $35.88 M   0.00% 1.36%
CORMORANT ASSET MANAGEMENT, LP 08/14/2026 550.00 K $30.36 M   -50.89% 1.15%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 515.28 K $28.44 M   188.03% 1.08%
GOLDMAN SACHS GROUP INC 08/14/2026 459.01 K $25.34 M   0.23% 0.96%
MARSHALL WACE, LLP 08/13/2026 401.89 K $22.18 M   540.93% 0.84%
ECOR1 CAPITAL, LLC 08/14/2026 388.50 K $21.45 M   -50.00% 0.81%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 346.72 K $19.14 M   18.21% 0.73%
BANK OF AMERICA CORP /DE/ 08/14/2026 298.93 K $16.50 M   939.75% 0.63%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 298.22 K $16.46 M   3.56% 0.63%
CANDRIAM S.C.A. 08/13/2026 289.89 K $15.99 M   -1.52% 0.61%
UBS GROUP AG 08/13/2026 272.75 K $15.06 M   -21.38% 0.57%
OPALEYE MANAGEMENT INC. 08/14/2026 260.00 K $14.35 M   0.00% 0.55%
FRANKLIN RESOURCES INC 08/13/2026 252.67 K $13.95 M   100.00% 0.53%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 248.67 K $13.73 M   100.84% 0.52%
MORGAN STANLEY 08/13/2026 248.56 K $13.72 M   687.52% 0.52%
NORTHERN TRUST CORP 08/13/2026 246.68 K $13.62 M   17.15% 0.52%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 233.70 K $12.90 M   399.86% 0.49%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 233.10 K $12.87 M   8.46% 0.49%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 233.10 K $12.87 M   100.00% 0.49%
MILLENNIUM MANAGEMENT LLC 08/14/2026 226.15 K $12.48 M   -59.93% 0.47%
TFG ASSET MANAGEMENT GP LTD 08/13/2026 203.54 K $11.24 M   39.91% 0.43%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 201.43 K $11.12 M   18.38% 0.42%
CAPTION MANAGEMENT, LLC 08/14/2026 200.00 K $11.04 M   100.00% 0.42%
CALIGAN PARTNERS LP 08/14/2026 200.00 K $11.04 M   -76.43% 0.42%
D. E. SHAW & CO., INC. 08/14/2026 182.77 K $10.09 M   -36.73% 0.38%
JPMORGAN CHASE & CO 08/12/2026 139.61 K $7.52 M   -5.06% 0.29%
KVP CAPITAL ADVISORS, LP 08/13/2026 121.52 K $6.71 M   0.00% 0.25%
TWO SIGMA INVESTMENTS, LP 08/14/2026 113.48 K $6.26 M   -1.39% 0.24%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 100.00 K $5.52 M   0.00% 0.21%

MBX Biosciences Inc. institutional Ownership - FAQ's

During the previous two years, 201 institutional investors and hedge funds held shares of MBX Biosciences Inc.. The most heavily invested institutionals were:

Frazier Life Sciences Management, L.P.: 6.65 M

FMR LLC: 5.32 M

WELLINGTON MANAGEMENT GROUP LLP: 4.98 M

NEA Management Company, LLC: 3.61 M

ORBIMED ADVISORS LLC: 3.43 M

BlackRock, Inc.: 3.32 M

116.81% of MBX Biosciences Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 57.56 M shares in the last 24 months. This purchase volume represents approximately $1.61 B in transactions.